CHRS

Coherus BioSciences $1.33 1M +13.7% 3M -6.3% YTD -2.9% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.8%
Next 1 week
+2.2%
Next 1 month
-0.1%
Seasonality
Weak window historically
Next 30 days (to Oct 13): -10.9% median, 36% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 32
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.07%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.89 +0.4% · Seasonal tilt (11y) -0.5%
$1M/day volume 81% volatility +2% 1-year
52-week range · 16% of the way up · -49% from the high
$1.09$2.62

Congressional trades in CHRS Full tracker →

1 member · 0 buys / 1 sells · $15K–$50K disclosed · latest filing Feb 9, 2023.

SELL ST Shri Thanedar · traded Jan 23, 2023 $15K–$50K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.